Jaguar Health, Inc. (JAGX)
0.66
0.00 (0.00%)
USD |
NASDAQ |
Feb 10, 16:00
0.66
0.00 (0.00%)
After-Hours: 20:00
Jaguar Health EPS Diluted (Quarterly) : -6.280 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | -0.0412 |
| Geron Corp. | -0.0276 |
| Corvus Pharmaceuticals, Inc. | -0.1226 |
| Rapt Therapeutics, Inc. | -0.652 |
| Recursion Pharmaceuticals, Inc. | -0.363 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.648M |
| Revenue (Quarterly) | 3.083M |
| Total Expenses (Quarterly) | 12.58M |
| Enterprise Value | 30.43M |
| Gross Profit Margin (Quarterly) | 64.58% |
| Profit Margin (Quarterly) | -312.9% |
| Earnings Yield | -5.15K% |
| Normalized Earnings Yield | -4437.29 |